Logo image of HERMA.OL

HERMANA HOLDING ASA (HERMA.OL) Stock Fundamental Analysis

OSL:HERMA - Euronext Oslo - NO0013401380 - Common Stock - Currency: NOK

10.85  0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to HERMA. HERMA was compared to 35 industry peers in the Energy Equipment & Services industry. HERMA has a great financial health rating, but its profitability evaluates not so good. HERMA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year HERMA was profitable.
In the past year HERMA has reported a negative cash flow from operations.
HERMA.OL Yearly Net Income VS EBIT VS OCF VS FCFHERMA.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 20M 40M 60M 80M

1.2 Ratios

HERMA has a worse Return On Assets (2.78%) than 62.86% of its industry peers.
HERMA has a Return On Equity of 2.80%. This is amonst the worse of the industry: HERMA underperforms 82.86% of its industry peers.
Industry RankSector Rank
ROA 2.78%
ROE 2.8%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HERMA.OL Yearly ROA, ROE, ROICHERMA.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 200 400 600

1.3 Margins

HERMA's Profit Margin of 47.89% is amongst the best of the industry. HERMA outperforms 94.29% of its industry peers.
In the last couple of years the Profit Margin of HERMA has declined.
The Operating Margin and Gross Margin are not available for HERMA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 47.89%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-22.65%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HERMA.OL Yearly Profit, Operating, Gross MarginsHERMA.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -100 -200

More info and screens

7

2. Health

2.1 Basic Checks

Compared to 1 year ago, HERMA has about the same amount of shares outstanding.
There is no outstanding debt for HERMA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HERMA.OL Yearly Shares OutstandingHERMA.OL Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M 8M 10M
HERMA.OL Yearly Total Debt VS Total AssetsHERMA.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

HERMA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
HERMA.OL Yearly LT Debt VS Equity VS FCFHERMA.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

HERMA has a Current Ratio of 127.33. This indicates that HERMA is financially healthy and has no problem in meeting its short term obligations.
HERMA has a Current ratio of 127.33. This is amongst the best in the industry. HERMA outperforms 97.14% of its industry peers.
A Quick Ratio of 127.33 indicates that HERMA has no problem at all paying its short term obligations.
HERMA has a Quick ratio of 127.33. This is amongst the best in the industry. HERMA outperforms 97.14% of its industry peers.
Industry RankSector Rank
Current Ratio 127.33
Quick Ratio 127.33
HERMA.OL Yearly Current Assets VS Current LiabilitesHERMA.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for HERMA have decreased strongly by -65.30% in the last year.
The earnings per share for HERMA have been decreasing by -49.24% on average. This is quite bad
HERMA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -62.14%.
HERMA shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -34.38% yearly.
EPS 1Y (TTM)-65.3%
EPS 3Y-49.24%
EPS 5YN/A
EPS Q2Q%528.16%
Revenue 1Y (TTM)-62.14%
Revenue growth 3Y-34.38%
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

The Earnings Per Share is expected to decrease by -115.44% on average over the next years. This is quite bad
The Revenue is expected to decrease by -25.99% on average over the next years. This is quite bad
EPS Next Y-900%
EPS Next 2Y-216.23%
EPS Next 3Y-115.44%
EPS Next 5YN/A
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
HERMA.OL Yearly Revenue VS EstimatesHERMA.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 20M 40M 60M 80M
HERMA.OL Yearly EPS VS EstimatesHERMA.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 -0.2 -0.4 -0.6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 43.40 indicates a quite expensive valuation of HERMA.
Compared to the rest of the industry, the Price/Earnings ratio of HERMA indicates a rather expensive valuation: HERMA more expensive than 80.00% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 28.88. HERMA is valued rather expensively when compared to this.
The Forward Price/Earnings Ratio is negative for HERMA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 43.4
Fwd PE N/A
HERMA.OL Price Earnings VS Forward Price EarningsHERMA.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HERMA.OL Per share dataHERMA.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

HERMA's earnings are expected to decrease with -115.44% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-216.23%
EPS Next 3Y-115.44%

More info and screens

0

5. Dividend

5.1 Amount

HERMA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HERMANA HOLDING ASA

OSL:HERMA (4/29/2025, 7:00:00 PM)

10.85

0 (0%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.36%
Inst Owner ChangeN/A
Ins Owners0.38%
Ins Owner ChangeN/A
Market Cap145.61M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-566.67%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-100%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 43.4
Fwd PE N/A
P/S 20.51
P/FCF N/A
P/OCF N/A
P/B 1.2
P/tB 1.2
EV/EBITDA N/A
EPS(TTM)0.25
EY2.3%
EPS(NY)-0.62
Fwd EYN/A
FCF(TTM)-0.63
FCFYN/A
OCF(TTM)-0.63
OCFYN/A
SpS0.53
BVpS9.05
TBVpS9.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.78%
ROE 2.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 47.89%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-22.65%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 127.33
Quick Ratio 127.33
Altman-Z N/A
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-65.3%
EPS 3Y-49.24%
EPS 5YN/A
EPS Q2Q%528.16%
EPS Next Y-900%
EPS Next 2Y-216.23%
EPS Next 3Y-115.44%
EPS Next 5YN/A
Revenue 1Y (TTM)-62.14%
Revenue growth 3Y-34.38%
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5YN/A
EBIT growth 1Y-396.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year0%
EBIT Next 3Y0%
EBIT Next 5YN/A
FCF growth 1Y-110.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-110.47%
OCF growth 3YN/A
OCF growth 5YN/A